Yaron Eitan - May 16, 2022 Form 4/A - Amendment Insider Report for Marpai, Inc. (MRAI)

Role: Director
Signature: /s/ Yaron Eitan
Stock symbol: MRAI
Transactions as of: May 16, 2022
Transactions value $: $365
Form type: 4/A - Amendment
Date filed: 5/23/2022, 04:03 PM
Date Of Original Report: May 18, 2022
Previous filing: Feb 22, 2022
Next filing: May 23, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRAI	Class A Common Stock	Purchase	$365	+271	+0.04%	$1.35	690K	May 18, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On May 18, 2022, the reporting person filed a Form 4 which incorrectly stated that he acquired 250 shares of Class A common stock of Marpai, Inc. (the "Company"). In fact, on May 18, 2022, the reporting person purchased 271 shares of the Company's Class A common stock. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.33 to $1.35, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).

Content

On May 18, 2022, the reporting person filed a Form 4 which incorrectly stated that he acquired 250 shares of Class A common stock of Marpai, Inc. (the "Company"). In fact, on May 18, 2022, the reporting person purchased 271 shares of the Company's Class A common stock. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.33 to $1.35, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).